跳轉至內容
Merck

In vitro susceptibilities of Mycoplasma putrefaciens field isolates.

Antimicrobial agents and chemotherapy (2007-07-20)
N T Antunes, M M Tavío, P Mercier, R D Ayling, W Al-Momani, P Assunção, R S Rosales, J B Poveda
摘要

MICs were determined for 15 antimicrobial agents against 37 Mycoplasma putrefaciens isolates. The most effective antimicrobial drug classes were the fluoroquinolones, the tetracyclines, the lincosamide lincomycin, and the macrolides. The susceptibility profile of the isolates correlated with the geographic origin. This is the first report of decreased susceptibility to the macrolides, lincomycin, and the tetracyclines in M. putrefaciens strains.

材料
產品編號
品牌
產品描述

Sigma-Aldrich
红霉素, BioReagent, suitable for cell culture
Sigma-Aldrich
环丙沙星, ≥98% (HPLC)
Sigma-Aldrich
萘啶酸, ≥98%
Sigma-Aldrich
恩诺沙星, ≥99.0%
Supelco
诺氟沙星, analytical standard, ≥98% (TLC)
Sigma-Aldrich
红霉素, potency: ≥850 μg per mg
Sigma-Aldrich
红霉素, meets USP testing specifications
Supelco
恩诺沙星, VETRANAL®, analytical standard
Supelco
环丙沙星, VETRANAL®, analytical standard
Supelco
诺氟沙星, VETRANAL®, analytical standard
Sigma-Aldrich
红霉素, tested according to Ph. Eur.